These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6112485)

  • 1. Potentiating action of rifampicin and isoniazid against Leishmania mexicana amazonensis.
    Peters W; Lainson R; Shaw JJ; Robinson BL; Leão AF
    Lancet; 1981 May; 1(8230):1122-4. PubMed ID: 6112485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileishmanial effects of clofazimine and other antimycobacterial agents.
    Evans AT; Croft SL; Peters W; Neal RA
    Ann Trop Med Parasitol; 1989 Oct; 83(5):447-54. PubMed ID: 2619361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rifampicin and isoniazid in cutaneous leishmaniasis.
    Livshin R; Weinrauch L; Even-Paz Z; el-On J
    Int J Dermatol; 1987; 26(1):55-9. PubMed ID: 3557792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of rifampicin and isoniazid against Leishmania tropica major.
    Livshin R; El-On J; Weinrauch L; Greenblatt CL; Even-Paz Z
    Int J Dermatol; 1983; 22(1):61. PubMed ID: 6832881
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The experimental chemotherapy of leishmaniasis, VI. The development of rodent models for cutaneous infection with L. major and L. mexicana amazonensis.
    Trotter ER; Peters W; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):299-319. PubMed ID: 7396564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran).
    Trnka L; Kvapilová M; Mison P
    Chemotherapy; 1976; 22(6):353-61. PubMed ID: 954481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of rifampicin and other antituberculous agents in chronic murine tuberculosis.
    Kradolfer F; Schnell R
    Chemotherapy; 1971; 16(3):173-82. PubMed ID: 5561406
    [No Abstract]   [Full Text] [Related]  

  • 10. Gatifloxacin in combination with rifampicin in a murine tuberculosis model.
    Cynamon M; Sklaney MR; Shoen C
    J Antimicrob Chemother; 2007 Aug; 60(2):429-32. PubMed ID: 17561504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The experimental chemotherapy of leishmaniasis, VII. Drug responses of L. major and L. mexicana amazonensis, with an analysis of promising chemical leads to new antileishmanial agents.
    Peters W; Trotter ER; Robinson BL
    Ann Trop Med Parasitol; 1980 Jun; 74(3):321-35. PubMed ID: 7396565
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies in vitro on infectivity and sensitivity to antileishmanial drugs in New World Leishmania species transfected with the green fluorescent protein [pIR3(-)-eGFP].
    Palacios G; Parodi A; Upegui YA; Montoya A; Pulido S; Vélez ID; Robledo SM
    Parasitology; 2017 Nov; 144(13):1718-1725. PubMed ID: 28831945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited therapeutic action of rifampicin/isoniazid against Leishmania aethiopica.
    van der Meulen J; Mock B; Fekete E; Sarojini PA
    Lancet; 1981 Jul; 2(8239):197-8. PubMed ID: 6114258
    [No Abstract]   [Full Text] [Related]  

  • 14. The action of rifampin alone and in combination with other antituberculous drugs.
    Hobby GL; Lenert TF
    Am Rev Respir Dis; 1970 Sep; 102(3):462-5. PubMed ID: 5456712
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs.
    Schreiber J; Zissel G; Greinert U; Schlaak M; Müller-Quernheim J
    Eur J Med Res; 1999 Feb; 4(2):67-71. PubMed ID: 10066642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases.
    Costa JM; Marsden PD; Llanos-Cuentas EA; Netto EM; Carvalho EM; Barral A; Rosa AC; Cuba CC; Magalhães AV; Barreto AC
    J Trop Med Hyg; 1986 Dec; 89(6):319-23. PubMed ID: 3806749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antileishmanial efficacy of a naphthoquinone derivate incorporated into a Pluronic
    Mendonça DVC; Tavares GSV; Lage DP; Soyer TG; Carvalho LM; Dias DS; Ribeiro PAF; Ottoni FM; Antinarelli LMR; Vale DL; Ludolf F; Duarte MC; Coimbra ES; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Barichello JM; Alves RJ; Coelho EAF
    Biomed Pharmacother; 2019 Jan; 109():779-787. PubMed ID: 30551531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Durable character of the sterilization of experimental tuberculosis in mice by rifampicin-isoniazid association: cortisone test].
    Grumbach F; Canetti G; Le Lirzin M
    Rev Tuberc Pneumol (Paris); 1970 Mar; 34(2):312-9. PubMed ID: 4994882
    [No Abstract]   [Full Text] [Related]  

  • 20. Antileishmanial Activity, Cytotoxicity and Mechanism of Action of Clioquinol Against Leishmania infantum and Leishmania amazonensis Species.
    Tavares GSV; Mendonça DVC; Lage DP; Granato JDT; Ottoni FM; Ludolf F; Chávez-Fumagalli MA; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):236-246. PubMed ID: 29481714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.